$1.52-0.04 (-2.56%)
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
Spectral AI, Inc. in the Healthcare sector is trading at $1.56 with a market capitalization of $53M. Wall Street consensus targets $5.11 (3 analysts), implying a +227.8% move over the next 12 months. The stock is currently 47% below its 52-week high of $2.97, remaining 8.2% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.52Mβ | $3.99Mβ | $4.09Mβ | $3.79Mβ | $5.07M |
| Gross Profit | $1.11Mβ | $2.03Mβ | $1.85Mβ | $1.62Mβ | $2.29M |
| Operating Income | -$4.32Mβ | -$1.97Mβ | -$2.24Mβ | -$3.34Mβ | -$2.12M |
| Net Income | -$4.18Mβ | -$3.41Mβ | $1.05Mβ | -$3.55Mβ | -$7.97M |
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damag...